4 Results for "

XDR-TB

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "XDR-TB" in MCE Product Catalog:

Cat. No.: HY-N8343
CAS No.: 62319-70-4
Arjunglucoside I, a natural compound, possesses antimicrobial activity with a MIC of 1.9 μg/mL .
loading...
    loading...
Cat. No.: HY-170970
Target:  

Bacterial

Research Areas:  

Infection

Mtb-IN-10 (Compound P15) is a Rv1625c/Cya activator that regulates cAMP metabolism to influence the growth of Mycobacterium tuberculosis (Mtb). Mtb-IN-10 exhibits an EC50 of 1.96 µM in an Mtb-infected macrophage model and demonstrates 58.0% oral bioavailability in mice at a 20 mg/kg dose. It may regulate intracellular signaling and disrupt cholesterol metabolism in Mtb, thereby inhibiting bacterial proliferation. Mtb-IN-10 holds potential for tuberculosis (TB) research, particularly for combating multidrug-resistant (MDR-TB) and extensively drug-resistant (XDR-TB) Mtb strains .
loading...
    loading...
Cat. No.: HY-151598
CAS No.: 3031462-75-3
Target:  

Bacterial

Research Areas:  

Infection

Pks13-TE inhibitor 2 (compound 32) is a 13-Thioesterase (Pks13-TE) inhibitor (IC50=1.30 μM). Pks13-TE inhibitor 2 shows good anti-tuberculosis activity against both agent-sensitive and drug-resistant Mtb strains (MIC=0.0039-0.0078 μg/mL). Pks13-TE inhibitor 2 can be used in studies of multidrug-resistant TB and extensively drug-resistant TB .
loading...
    loading...
Cat. No.: HY-151599
CAS No.: 3031462-62-8
Target:  

Bacterial

Research Areas:  

Infection

Pks13-TE inhibitor 3 (compound 23) is a 13-Thioesterase (Pks13-TE) inhibitor (IC50=1.55 μM). Pks13-TE inhibitor 3 shows good anti-tuberculosis activity against both agent-sensitive and drug-resistant Mtb strains (MIC=0.0625-0.25 μg/mL). Pks13-TE inhibitor 3 can be used in studies of multidrug-resistant TB and extensively drug-resistant TB .
loading...
    loading...